Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
Therapeutic Advances in Neurological Disorders
|
March 6, 2023
Microglia as a cellular target of diclofenac therapy in Alzheimer's disease
Barbara E Stopschinski, Rick A Weideman, Danni McMahan, et al.
Therapeutic Advances in Neurological Disorders
|
April 19, 2024
A review of Bruton's tyrosine kinase inhibitors in multiple sclerosis
Laura Airas, Robert A Bermel, Tanuja Chitnis, et al.
Journal of Central Nervous System Disease
|
September 5, 2022
The sequential natalizumab - alemtuzumab therapy in patients with relapsing forms of multiple sclerosis (SUPPRESS) trial - Part I: Rationale and objectives
Rehana Z Hussain, Peter V Sguigna, Annette Okai, et al.
Therapeutic Advances in Neurological Disorders
|
February 8, 2021
Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials
Yinan Zhang, Natalia Gonzalez Caldito, Afsaneh Shirani, et al.
Journal of the American College of Radiology : JACR
|
December 10, 2016
Effect of Template Reporting of Brain MRIs for Multiple Sclerosis on Report Thoroughness and Neurologist-Rated Quality: Results of a Prospective Quality Improvement Project
Elliot Dickerson, Matthew S Davenport, Faiz Syed, et al.
Frontiers in Immunology
|
July 30, 2019
Immunological Aspects of Approved MS Therapeutics
Paulus S Rommer, Ron Milo, May H Han, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 21, 2009
Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune disease
Anne R Gocke, Rehana Z Hussain, Yuhong Yang, et al.
Brain : a Journal of Neurology
|
October 3, 2007
Autologous HSCT for advanced MS: is the glass half-empty or really half-full?
Richard A Nash, Olaf Stuve, James D Bowen, et al.
Therapeutic Advances in Neurological Disorders
|
April 8, 2024
Cladribine tablets after treatment with natalizumab (CLADRINA) - rationale and design
Peter V Sguigna, Rehana Z Hussain, Annette Okai, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 16, 2015
B lymphocytes in neuromyelitis optica
Jeffrey L Bennett, Kevin C O'Connor, Amit Bar-Or, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
Therapeutic Advances in Neurological Disorders
|
March 6, 2023
Microglia as a cellular target of diclofenac therapy in Alzheimer's disease
Barbara E Stopschinski, Rick A Weideman, Danni McMahan, et al.
Therapeutic Advances in Neurological Disorders
|
April 19, 2024
A review of Bruton's tyrosine kinase inhibitors in multiple sclerosis
Laura Airas, Robert A Bermel, Tanuja Chitnis, et al.
Journal of Central Nervous System Disease
|
September 5, 2022
The sequential natalizumab - alemtuzumab therapy in patients with relapsing forms of multiple sclerosis (SUPPRESS) trial - Part I: Rationale and objectives
Rehana Z Hussain, Peter V Sguigna, Annette Okai, et al.
Therapeutic Advances in Neurological Disorders
|
February 8, 2021
Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials
Yinan Zhang, Natalia Gonzalez Caldito, Afsaneh Shirani, et al.
Journal of the American College of Radiology : JACR
|
December 10, 2016
Effect of Template Reporting of Brain MRIs for Multiple Sclerosis on Report Thoroughness and Neurologist-Rated Quality: Results of a Prospective Quality Improvement Project
Elliot Dickerson, Matthew S Davenport, Faiz Syed, et al.
Frontiers in Immunology
|
July 30, 2019
Immunological Aspects of Approved MS Therapeutics
Paulus S Rommer, Ron Milo, May H Han, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 21, 2009
Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune disease
Anne R Gocke, Rehana Z Hussain, Yuhong Yang, et al.
Brain : a Journal of Neurology
|
October 3, 2007
Autologous HSCT for advanced MS: is the glass half-empty or really half-full?
Richard A Nash, Olaf Stuve, James D Bowen, et al.
Therapeutic Advances in Neurological Disorders
|
April 8, 2024
Cladribine tablets after treatment with natalizumab (CLADRINA) - rationale and design
Peter V Sguigna, Rehana Z Hussain, Annette Okai, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 16, 2015
B lymphocytes in neuromyelitis optica
Jeffrey L Bennett, Kevin C O'Connor, Amit Bar-Or, et al.
Page
of 9